2025年10月27日，金城医药(300233.SZ)发布2025年第三季报。截至2025年10月26日，共有9个机构投资 者披露持有金城医药A股股份，合计持股量达1.13亿股，占金城医药总股本的29.44%。其中，机构投资 者包括淄博金城实业投资股份有限公司、全国社保基金五零二组合、中国建设银行股份有限公司-富国 精准医疗灵活配置混合型证券投资基金、青岛富和投资有限公司、基本养老保险基金二一零八组合、全 国社保基金六零一组合、香港中央结算有限公司、招商银行股份有限公司-兴全轻资产投资混合型证券 投资基金(LOF)、国泰佳泰股票专项型养老金产品-招商银行股份有限公司，机构投资者合计持股比例达 29.44%。相较于上一季度，机构持股比例合计上涨了4.77个百分点。 公募基金方面，本期较上一季度新披露的公募基金共计2个，包括富国精准医疗灵活配置混合A、兴全 轻资产混合(LOF)。本期较上一季未再披露的公募基金共计14个，主要包括大成景恒混合A、大成卓享 一年持有混合A、太平嘉和三个月定开债券发起式、平安添悦债券A、国泰融安多策略灵活配置混合A 等。 对于社保基金，本期新披露持有金城医药的社保基金共计2个，包括全国 ...

Group 1 - The core viewpoint of the news is that Wanrun New Energy has seen a significant increase in stock price, rising by 5.37% to reach 65.70 CNY per share, with a trading volume of 4.92 billion CNY and a turnover rate of 9.24%, resulting in a total market capitalization of 8.286 billion CNY [1] - Wanrun New Energy, established on December 24, 2010, and listed on September 29, 2022, specializes in the research, production, sales, and service of lithium battery cathode materials, with its main business revenue composition being 96.49% from lithium iron phosphate, 2.83% from by-products, 0.41% from iron phosphate, and 0.27% from other sources [1] Group 2 - From the perspective of fund holdings, Dachen Fund has a significant position in Wanrun New Energy, with its Dachen Zhuo Xiang One-Year Holding Mixed A Fund holding 67,200 shares, accounting for 1.2% of the fund's net value, ranking as the tenth largest holding [2] - The Dachen Zhuo Xiang One-Year Holding Mixed A Fund, established on November 16, 2020, has a current scale of 208 million CNY, with a year-to-date return of 8.79%, ranking 6129 out of 8234 in its category, and a one-year return of 12.77%, ranking 5310 out of 8083 [2] - The fund manager, Su Bingyi, has a tenure of 13 years and 251 days, with the fund's total asset scale at 1.24 billion CNY, achieving a best return of 246% and a worst return of -71.74% during his tenure [2]